ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?

Abstract

This article deals with current issues of pharmacotherapy of cardiovascular diseases which are based on disfunction of the renin-angiotensin-aldosterone system. As compared with the efficacy and safety of two major classes of drugs for the pharmacotherapy of cardiovascular diseases — angiotensin II receptor blockers and ACE inhibitors — are given data from clinical trials of both classes of drugs.

Keywords

• renin-angiotensin-aldosterone system
• angiotensin receptor blockers ii
• sartana
• ace inhibitors
• pharmacotherapy of cardiovascular disease